Prevalence and predictors of microalbuminuria in patients with diabetes mellitus: A cross-sectional observational study in Kumasi, Ghana

Ethnicity and Disease

Volumn 17, Issue 4, 2007, Pages 726-730

  Eghan Jr , Benjamin A ^a,b   Frempong, Magaret T ^a   Adjei Poku, Micheal ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b NONE   (Ghana)

Author keywords

Diabetes mellitus; Diabetic nephropathy; End stage renal disease; Microalbuminuria

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; POTASSIUM; TRIACYLGLYCEROL; UREA;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GHANA; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTPATIENT; POTASSIUM URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ALBUMINURIA; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; GHANA; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 36348992644     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andersen AR, Christiansen SJ, Andersen JK, et al. Diabetic nephropathy in type one insulin dependent diabetes: an epidemiological study. Diabetologia. 1983;25:496-501.
2. Tung P, Levin SR. Nephropathy in non-insulin-dependent diabetes mellitus. Am J Med. 1988;85(Suppl 5A):131-136.
3. Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074-1079.
4. Sirmon MD. Renal disease in non-insulin-dependent diabetes mellitus. Am J Med Sci. 1990;300:388-395.
5. Mogensen CE, Schmitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North America. 1988;72:1465-1492.
6. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815-819.
7. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearence in men: a cross-sectional and longitudinal study. J Gerontology. 1976;31:155-163.
8. Virga G, Gaspari F, Thomaseth K, Cara M, Mastrosimone S, Rossi V. A new equation for estimating renal function using age, body weight and serum creatinine. Nephron Clin Pract. 2007;105(2):c43-53.
9. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
10. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;ii:530-533.
11. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
12. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh.). 1982;100:550-555.
13. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1: 1430-1432.
14. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356-360.
15. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. European Heart Journal. 2000;21: 1922-1927.
16. Remuzzi G, Schiepati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145-1151.
17. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulindependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157:1413-1418.
18. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-1462.
19. Molnar M, Wittmann I, Nagy J. Prevalence, course and risk factors of diabetic nephropathy in type 2 diabetes mellitus: Med Sci Monit. 2000;6(5):929-936.
20. Tentolouris N, Stylianou A, Lourida E. High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria. J Lipid Res. 2007;48(1):218-225.
21. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63: 225-232.
22. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004;328:1105-1108.
23. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25: 496-501.
24. Wong TY, Shankar A, Klein R, Klein BE. Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes. 2004;53:179-184.
25. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000;160: 1093-1100.